Section Arrow
NPCE.NASDAQ
- Neuropace
Quotes are at least 15-min delayed:2025/06/28 15:00 EDT
Last
 10.71
-0.23 (-2.10%)
Day High 
11.044883 
Prev. Close
10.94 
1-M High
14.75 
Volume 
2.29M 
Bid
10.2
Ask
11
Day Low
10.32 
Open
11 
1-M Low
9.845 
Market Cap 
358.82M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 10.8 
20-SMA 11.91 
50-SMA 12.69 
52-W High 18.975 
52-W Low 5.45 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.82/-0.52
Enterprise Value
430.29M
Balance Sheet
Book Value Per Share
0.74
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
79.91M
Operating Revenue Per Share
1.84
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed:2025/06/28 15:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.